About Laura Stoppel
Laura Stoppel is a director at Infinant Health.
Laura Stoppel reports to the SEC as a director of 2 public companies: Artiva Biotherapeutics (ARTV) and Acumen Pharmaceuticals (ABOS).
Laura Stoppel first appears on SEC filings in 2021.
Experience
This experience comes from Laura Stoppel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Laura Stoppel in the role, so the role may have started earlier or lasted longer.
Infinant Health, Inc. Current
Director
2026 – Present · Sacramento, CA
Makes infant probiotic products for parents and develops a treatment for premature babies.
VB
Verdiva Bio Current
Board Member
2024 – Present
CE
CellCentric Current
Board Member
2024 – Present
IF
International Rett Syndrome Foundation Current
Board Member
2023 – Present
AI
Artiva Biotherapeutics, Inc. Current
Director
2020 – Present · Public company (ARTV)
AI
Acumen Pharmaceuticals, Inc. Current
Director
2020 – Present · Public company (ABOS)
NT
Nimbus Therapeutics Current
Board Member
2020 – Present
RM
RA Capital Management Current
Partner (2016 – Present)
Senior Associate (2018 – 2020)
2016 – Present
Key Colleagues at Startups
The people Laura Stoppel works with at each company, as listed on that company's latest Form D.
Infinant Health, Inc. · Form D, Jun 8, 2026
Michael Johnson
Chief Executive Officer and director
ML
Mike Liang
Director
Amanda Birdsey-Benson
Independent Board Member
RW
Roger Wyse
Director
Patrick Enright
Director
Katharine Knobil
Scientific Advisor and director